RIO DE JANEIRO, BRAZIL - Publicly traded Brazilian medical services firm Diagnósticos da América SA, known as DASA, said on Monday, March 15th, that in a securities filing that the board of the company has approved a proposed acquisition of two rival medical companies.
According to the filing, the board authorized its wholly owned subsidiary Ímpar Serviços Hospitalares SA to buy up to 100% of the stock of Andrade da Silva Participações SA and . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here